Non-small cell lung cancer in the new millennium: The effect of FDG-PET on stage distribution.

被引:0
|
作者
Goodgame, B.
Morgensztern, D.
Grove, L.
Govindan, R.
机构
[1] Barnes Jewish Hosp, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7205
引用
收藏
页码:415S / 415S
页数:1
相关论文
共 50 条
  • [21] FDG-PET SUVmax Does Not Correlate with Glucose Metabolism in Non-Small Cell Lung Cancer
    Kernstine, Kemp
    Faubert, Brandon
    Hensley, Christopher
    Cai, Ling
    Torrealba, Jose
    Oliver, Dwight
    Lenkinski, Robert
    Malloy, Craig
    Deberardinis, Ralph
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S554 - S554
  • [22] FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet
    Stirling, Rob G.
    Zalcberg, John
    ANNALS OF THORACIC SURGERY, 2020, 109 (05): : 1624 - 1624
  • [23] Pretreatment prediction of prognosis by FDG-PET in patients with non-small cell lung cancer.
    Sasaki, M
    Kuwabara, Y
    Koga, H
    Nakagawa, M
    Hayashi, K
    Kaneko, K
    Chen, T
    Masuda, K
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 301P - 301P
  • [24] FDG-PET and CT features of non-small cell lung cancer based on tumor type
    Aquino, Suzanne L.
    Halpern, Elkan F.
    Kuester, Landon B.
    Fischman, Alan J.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (03) : 495 - 499
  • [25] Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer
    Sunaga, Noriaki
    Oriuchi, Noboru
    Kaira, Kyoichi
    Yanagitani, Noriko
    Tomizawa, Yoshio
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Endo, Keigo
    Mori, Masatomo
    LUNG CANCER, 2008, 59 (02) : 203 - 210
  • [26] Association between FDG-PET and tumor vitality: Understanding the prognostic value of FDG uptake in early stage non-small cell lung cancer
    Dooms, C.
    van Baardwijk, A.
    Verbeken, E.
    van Suylen, R.
    De Ruysscher, D.
    Vansteenkiste, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] The role of FDG-PET in the staging of non-small cell lung cancer from a health technology perspective
    Verboom, P.
    Uyl-de Groot, C. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S103 - S103
  • [28] Characterizing Heterogeneous Responses to Systemic Therapy in Non-small Cell Lung Cancer Using FDG-PET
    Lee, A.
    Abraham, T.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E472 - E472
  • [29] Plausibility and redundancy analysis to select FDG-PET textural features in non-small cell lung cancer
    Pfaehler, Elisabeth
    Mesotten, Liesbet
    Zhovannik, Ivan
    Pieplenbosch, Simone
    Thomeer, Michiel
    Vanhove, Karolien
    Adriaensens, Peter
    Boellaard, Ronald
    MEDICAL PHYSICS, 2021, 48 (03) : 1226 - 1238
  • [30] FDG-PET/CT in pulmonary and cardiac Langerhans' cell histiocytosis and metastatic non-small cell lung cancer
    Schreiber, Jens
    Waldburg, Nadine
    NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (08) : 1173 - 1174